Trastuzumab Completed Phase 1 Trials for Breast Cancer Metastatic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00199212PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2